|
|
Innovative anticancer agents reserved to hospital use and not involved in the hospital budget: Creation and evolution
Gilles Freyer
,
Michel Marty
,
Jean-Yves Blay
,
Bruno Chauffert
,
Gerard Ganem
,
et al.
Article dans une revue
hal-03598686v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study
Diane Goere
,
Olivier Glehen
,
Francois Quenet
,
Jean-Marc Guilloit
,
Jean-Marc Bereder
,
et al.
Article dans une revue
hal-03597470v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis
Pierre-Emmanuel Bonnot
,
Guillaume Piessen
,
Vahan Kepenekian
,
Evelyne Decullier
,
Marc Pocard
,
et al.
Article dans une revue
hal-03595882v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Major hepatectomy for intrahepatic cholangiocarcinoma or colorectal liver metastases. Are we talking about the same story?
Alexandre Doussot
,
David Fuks
,
Jean-Marc Regimbeau
,
Olivier Farges
,
Antonio Sa-Cunha
,
et al.
Article dans une revue
hal-03595877v1
|
Partager
Gmail
Facebook
Twitter
LinkedIn
More
|